High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment
Yuta Ushida, Yosuke Inoue, Hiromichi Ito, Atsushi Oba, Yoshihiro Mise, Yoshihiro Ono, Takafumi Sato, Akio Saiura, Yu Takahashi
Topics & Concepts
MedicineHazard ratioCA19-9Pancreatic cancerInternal medicineOncologyOverall survivalGastroenterologySurgeryCancerConfidence intervalPancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentInflammatory Biomarkers in Disease Prognosis